Cargando…
Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients
BACKGROUND: Renal impairment (RI) is associated with poor survival in newly diagnosed multiple myeloma (MM) patients. Renal function recovery has been one of the main therapeutic goals in those patients. METHODS: The records from 393 newly diagnosed MM patients in our hospital between January 2012 a...
Autores principales: | Chen, Xuduan, Luo, Xiaofeng, Zu, Yanping, Issa, Hajji Ally, Li, Linlin, Ye, Hong, Yang, Ting, Hu, Jianda, Wei, Lixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521223/ https://www.ncbi.nlm.nih.gov/pubmed/32710448 http://dx.doi.org/10.1002/jcla.23416 |
Ejemplares similares
-
Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma
por: Khan, R, et al.
Publicado: (2015) -
Echocardiography‐defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients
por: Jian, Yuan, et al.
Publicado: (2022) -
Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Zhang, Yue, et al.
Publicado: (2019) -
P909: RENAL RESPONSE OF POMALIDOMIDE WITH BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH RENAL IMPAIRMENT
por: Jian, Y., et al.
Publicado: (2022) -
Bortezomib overcomes the negative prognostic impact of renal impairment in a newly diagnosed elderly patient with multiple myeloma: A case report
por: Wu, Tao, et al.
Publicado: (2017)